Drugs / gamma-tocotrienol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02230800 | Nov 2014 → Dec 2019 | — | Royal Marsden NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gamma-tocotrienol | “nutritional supplement containing gamma-tocotrienol (Tocovid SupraBio), a substance derived from palm oil” NCT02230800 ↗ |
| Modality | Small molecule | — CHEMBL120697 ↗ |
| Route | Oral | “Tocovid SupraBio 200 mg and pentoxifylline 400 mg orally twice daily for one year” PMID 35093409 ↗ Jan 2022 |